Compugen Stock In The News

CGEN Stock  USD 1.63  0.02  1.21%   
Our overall analysis of Compugen's news coverage and content from conventional and social sources shows investors' bearish mood towards Compugen. The specific impact of Compugen news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Compugen's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Compugen headlines in addition to utilizing other, more conventional financial analysis modules. Check out Compugen Backtesting and Compugen Hype Analysis.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Compugen Today Top News and Investor Outlook

Yahoo News
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
https://finance.yahoo.com/news/compugen-receive-milestone-payment-triggered-110000791.html
 Neutral
Yahoo News
Compugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/compugen-ltd-nasdaq-cgen-q4-144124073.html
 Bullish
Yahoo News
7 Speculative Stocks to Double Your Money THIS Year
https://finance.yahoo.com/news/7-speculative-stocks-double-money-031430541.html
 Bullish
Yahoo News
Compugen to Receive $10 Million Mileston...
https://finance.yahoo.com/news/compugen-receive-10-million-milestone-120500521.html
 Neutral
Yahoo News
Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement
https://finance.yahoo.com/news/compugen-regains-compliance-nasdaq-minimum-120000043.html
 Neutral
Yahoo News
Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
https://finance.yahoo.com/news/biotech-stock-roundup-cgen-gild-163900148.html
 Bullish
Yahoo News
Gilead (GILD), Compugen Collaborate for Immunotherapy Program
https://finance.yahoo.com/news/gilead-gild-compugen-collaborate-immunotherapy-153300112.html
 Bullish
Yahoo News
Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone
https://finance.yahoo.com/news/compugen-nasdaq-cgen-delivers-shareholders-102740484.html
 Bullish
Yahoo News
Compugen will be Eligible to Receive $10...
https://finance.yahoo.com/news/compugen-eligible-receive-10-million-121000149.html
 Neutral
Yahoo News
Compugen to Host Conference Call to Disc...
https://finance.yahoo.com/news/compugen-host-conference-call-discuss-120500402.html
 Neutral

Compugen Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Compugen and other traded companies coverage with news coverage. We help investors stay connected with Compugen headlines for the 11th of December 2024 to make an informed investment decision based on correlating the impacts of news items on Compugen Stock performance. Please note that trading solely based on the Compugen hype is not for everyone as timely availability and quick action are needed to avoid losses.
Compugen's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Compugen investors visualize upcoming and past events in order to time the market based on Compugen noise-free hype analysis.
Compugen stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Compugen earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. That information is available publicly through Compugen media outlets and privately through word of mouth or via Compugen internal channels. However, regardless of the origin, that massive amount of Compugen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Largest EPS Surprises

Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2011-11-08
2011-09-30-0.09-0.1-0.0111 
2011-05-11
2011-03-31-0.07-0.060.0114 
2010-02-09
2009-12-31-0.08-0.070.0112 
2009-10-27
2009-09-30-0.07-0.060.0114 
2023-11-07
2023-09-30-0.09-0.11-0.0222 
2020-07-30
2020-06-30-0.1-0.080.0220 
View All Earnings Estimates

Compugen Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Compugen Stock. Current markets are slightly bearish. About 55% of major world exchanges and indexes are down. See today's market update for more information.
Gurufocus Stories at Macroaxis
6th of December 2024
Compugen Stock Surges Amid Biotech Industry Movement
at gurufocus.com 
Yahoo News
20th of November 2024
Converge Bio raises 5.5M Seed to speed up drug discovery and development with Generative A...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
14th of November 2024
Compugen Stock Declines Amidst Industry Downtrend
at gurufocus.com 
Investing News at Macroaxis
13th of November 2024
Earnings call Compugen reports promising data and financial growth in Q3
at investing.com 
zacks News
12th of November 2024
Compugen Q3 Earnings and Revenues Lag Estimates
at zacks.com 
Gurufocus Stories at Macroaxis
6th of November 2024
Compugen Stock Surges Amidst Biotech Sector Volatility
at gurufocus.com 
Yahoo News
4th of November 2024
Compugen Strengthens Defence Security Industry with Strategic Acquisition of SynerSolution...
at finance.yahoo.com 
businesswire News
30th of October 2024
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients wi...
at businesswire.com 
news
27th of September 2024
Critical Survey Compugen versus Halberd
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Compugen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Compugen's short interest history, or implied volatility extrapolated from Compugen options trading.
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Compugen Backtesting and Compugen Hype Analysis.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.03
Revenue Per Share
0.48
Quarterly Revenue Growth
3.461
Return On Assets
(0.03)
Return On Equity
(0.16)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.